Newsletter Signup | Join Community
Not all lung cancer cells are alike - over half can now be treated with precision medicines targeting specific mutations
Chemotherapy, biomarker testing and precision cancer medicines and immunotherapy are used to treat stage IIIB-IV NSCLC.
TKI therapy for EGFR + NSCLC continue to evolve and improve survival. Tagrisso resistance mutation recently identified.
Family History of Lung Cancer Doubles Risk
Alunbrig Continues to Demonstrate Superiority in the First - Line After Two Years of Follow-Up for ALK + NSCLC
Opdivo® immunotherapy is used effectively both as initial treatment and in the management of recurrent NSCLC.
What is the evidence and current recommendations for lung cancer screening?
Tarceva™ Improves Survival in Non-Small Cell Lung Cancer
I have small cell lung cancer; radiation to prevent spread to the brain has been recommended but…
HER 2 + Lung Cancer Treatment? https://coloradocancerblogs…
Dana Farber and MDACC discover why anti-PD 1 immunotherapy doesnt work in some patients and work to…
High incidence of ROS 1 false negative tests reported by U Colorado researchers. http://www…